CDK2 and renal cell carcinoma: In renal cell carcinoma (RCC), WTAP promoted the mRNA stability of Cdk2, a regulator of cell cycle control over the G1/S and S/G2 transition, by directly binding to the Cdk2 transcript at the 3′-UTR (Tang et al., 2018).